3i, LP 13D and 13G filings for Chromocell Therapeutics Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-13 4:05 pm Sale |
2024-09-30 | 13G | Chromocell Therapeutics Corporation CHRO |
3i, LP | 301,000 4.990% |
-17,823 (-5.59%) |
Filing |
| 2024-03-01 5:07 pm Purchase |
2024-02-21 | 13G | Chromocell Therapeutics Corporation CHRO |
3i, LP | 318,823 5.500% |
318,823 (New Position) |
Filing |